FratFiles

• Save Paper

Determinants and consequences of M&A activity in the pharmaceutical – biotechnological industry

Alisher Saydalikhodjayev
March 30, 2008
Industrial Organization
Professor J. Likens

ABSTRACT
Traditionally, pharmaceutical firms with large R&D platforms dominated the space of drug innovation; however, the last 30 years produced a large number of smaller research-oriented biotech firms. Advances in the human genome project opened doors to the field of drug innovation to many new players. This event caused a change in the structure of the pharmaceutical-biotech industry, primarily through a hike in M&A activity during the 80’s and the 90’s. The examined study found that large pharmaceutical firms that had gaps in their drug development pipeline tended to engage in acquisitions, while small biotech firms that experienced financial trouble tended to participate in M&A as targets. At the same time, small biotech firms that had promising drug development pipelines and healthy......

View the rest of this paper...

Approximate Word Count: 6740
Approximate Pages: 27 (250 words per double-spaced page)

Similar Essays

1. M&Amp;Amp;A In Biotech Industry
   

   M&Amp;A In Biotech Industry Determinants and consequences of M&A activity in the pharmaceutical - biotechnological industry Alisher Saydalikhodjayev March 30, 2008 Industrial

2. 
   

3. 
   

4. 
   

5.